5-(4-chlorophenyl)indole-2-carboxylic acid ethyl ester | 825623-68-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 5-(4-chlorophenyl)indole-2-carboxylic acid ethyl ester
• 英文别名: ethyl 5-(4-chlorophenyl)-1H-indole-2-carboxylate
• CAS: 825623-68-5
• 化学式: C₁₇H₁₄ClNO₂
• 分子量: 299.757
• InChiKey: MLWGRVSVXUJEMC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.4
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  42.1
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• [EN] IDOLES USEFUL IN THE TREATMENT OF INFLAMMATION<br/>[FR] INDOLES UTILISES DANS LE TRAITEMENT DE L'INFLAMMATION
  申请人：BIOLIPOX AB

  公开号：WO2005005415A1

  公开（公告）日：2005-01-20

  There is provided a compound of formula (I), wherein X, Y, Z, R1, R2, R3, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of microsomal prostaglandin E synthase-1 is desired and/or required, and particularly in the treatment of inflammation.

  提供一种化合物，其化学式为（I），其中X、Y、Z、R1、R2、R3、R4和R5的含义如描述中所述，并且其药用盐，这些化合物在治疗需要或期望抑制微粒体前列腺素E合成酶-1活性的疾病中非常有用，特别是在炎症治疗中。
• Indoles useful in the treatment of inflammation
  申请人：Olofsson Kristofer

  公开号：US20060160879A1

  公开（公告）日：2006-07-20

  There is provided a compound of formula (I), wherein X, Y, Z, R 1 , R 2 , R 3 , R 4 , and R 5 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of microsomal prostaglandin E synthase-1 is desired and/or required, and particularly in the treatment of inflammation.

  提供了一种化合物，其化学式为(I)，其中X、Y、Z、R1、R2、R3、R4和R5的含义如描述中所给，以及其药学上可接受的盐。这些化合物在治疗需要抑制微粒体前列腺素E合成酶-1活性的疾病，尤其是在治疗炎症方面具有用处。
• AGENT FOR CONTROLLING FUNCTION OF GPR34 RECEPTOR
  申请人：Takeda Pharmaceutical Company Limited

  公开号：EP1849465A1

  公开（公告）日：2007-10-31

  The present invention provides a GPR receptor function regulator comprising the compound represented by the formula: [wherein ring A is an optionally substituted isocyclic or heterocyclic ring, P is a bond or spacer, ring D is an optionally substituted monocyclic aromatic ring which may be condensed with a 5-to 7-membered ring, V is a bond or the group represented by the formula -CR14=CR15 - or - N=CR16- (wherein R14, R15 and R16 each represents a hydrogen atom or optionally substituted hydrocarbon group), Q is a bond or spacer, and W is a carboxyl or a group biologically equivalent to a carboxyl] or its salt or a prodrug thereof

  本发明提供了一种 GPR 受体功能调节剂，包括由式表示的化合物： [其中环A是任选取代的异环或杂环，P是键或间隔物，环D是任选取代的单环芳香环，可与5-7元环缩合，V是键或由式-CR14＝CR15-或-N＝CR16-代表的基团（其中R14、R15 和 R16 各代表一个氢原子或任选取代的烃基），Q 是键或间隔物，W 是羧基或生物等价于羧基的基团]或其盐或其原药
• INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION
  申请人：Biolipox AB

  公开号：EP1646624A1

  公开（公告）日：2006-04-19
• Regulating Agent of GPR34 Receptor Function
  申请人：Itoh Fumio

  公开号：US20100130737A1

  公开（公告）日：2010-05-27

  The present invention provides a GPR receptor function regulator comprising the compound represented by the formula: [wherein ring A is an optionally substituted isocyclic or heterocyclic ring, P is a bond or spacer, ring D is an optionally substituted monocyclic aromatic ring which may be condensed with a 5- to 7-membered ring, V is a bond or the group represented by the formula —CR 14 ═CR 15 — or —N═CR 16 — (wherein R 14 , R 15 and R 16 each represents a hydrogen atom or optionally substituted hydrocarbon group), Q is a bond or spacer, and W is a carboxyl or a group biologically equivalent to a carboxyl] or its salt or a prodrug thereof.